Application of highly sensitive UPLC–MS to determine biodistribution at tracer doses: validation with the 5-HT1A ligand [18F]FPWAY
To access this article, please choose from the options below
PII: S0969-8051(09)00002-X
doi:10.1016/j.nucmedbio.2009.01.002
Published by Elsevier Inc.
